Concepedia

Luke Norton

LN

Statistics

Publications

40

Citations

3.1K

H-Index

27

Active since

2001

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

University of Nottingham

Queen's Medical Centre

Texas Diabetes Institute

The University of Texas at San Antonio

Luke Norton is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, diabetes, and metabolism.

ORCID

Top concepts

Publications per year

2001–2023

40

Publications

40

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

Aurora Merovci, Carolina Solis‐Herrera, Giuseppe Daniele et al. · Journal of Clinical Investigation · 2014 · 769 citations · Full text

, , +15

Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30–50% of Filtered Glucose Load in Humans

Muhammad Abdul‐Ghani, Ralph A. DeFronzo, Luke Norton · Diabetes · 2013 · 236 citations · Full text

Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes

Giuseppe Daniele, Juan Xiong, Carolina Solis‐Herrera et al. · Diabetes Care · 2016 · 206 citations · Full text

Lactate Elicits ER-Mitochondrial Mg2+ Dynamics to Integrate Cellular Metabolism

Cassidy C. Daw, R. Karthik, Benjamin T. Enslow et al. · Cell · 2020 · 188 citations · Full text

, , +7

The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function

Xi Chen, Iriscilla Ayala, Chris E. Shannon et al. · Diabetes · 2018 · 142 citations

1–5 of 40